http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100554901-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 1997-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100554901-B1 |
| titleOfInvention | RET Ligand to stimulate nerve and kidney proliferation |
| abstract | The present invention relates to a nucleotide sequence encoding Ret Ligand (RetL) and a method for promoting nerve and kidney proliferation by treating cell and mammalian specimens with RetL DNA or protein. The present invention has the nucleotide sequence of any RetL, but in particular rat retL1 cDNA (SEQ ID NO: 1), partial human retL1 cDNA (SEQ ID NO: 8), full length human retL1 cDNA (SEQ ID NO: 10), human retL2 cDNA (SEQ ID NO: 12) Purified and isolated DNA encoding RetL, including murine retL3 cDNA (SEQ ID NO: 12) or human RetL3 cDNA (SEQ ID NO: 16), partial human retL3 cDNA (SEQ ID NO: 18) or human retL3 cDNA (SEQ ID NO: 20) Provide a molecule. In addition, the present invention provides an amino acid sequence of rat RetL1 (SEQ ID NO: 2), partial human RetL1 (SEQ ID NO: 9), full length human RetL1 (SEQ ID NO: 11), human RetL2 (SEQ ID NO: 13), rat RetL3 (SEQ ID NO: 17), Provided is a RetL protein comprising the amino acid sequence of partially human RetL3 (SEQ ID NO: 19) or human RetL3 (SEQ ID NO: 21). |
| priorityDate | 1996-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 507.